223 related articles for article (PubMed ID: 27128943)
21. [Role of tumor necrosis factor-alpha in the anti-HBV activity of tetracycline].
Ni Y; Jiang F; Xu H; Zeng T; Lei Y; Chen Y; Zhou Z; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):213-8. PubMed ID: 24824125
[TBL] [Abstract][Full Text] [Related]
22. Anti-HBV Activities of Three Compounds Extracted and Purified from Herpetospermum Seeds.
Gong PY; Yuan ZX; Gu J; Tan R; Li JC; Ren Y; Hu S
Molecules; 2016 Dec; 22(1):. PubMed ID: 28035986
[TBL] [Abstract][Full Text] [Related]
23. Epigallocatechin gallate inhibits hepatitis B virus infection in human liver chimeric mice.
Lai YH; Sun CP; Huang HC; Chen JC; Liu HK; Huang C
BMC Complement Altern Med; 2018 Sep; 18(1):248. PubMed ID: 30189898
[TBL] [Abstract][Full Text] [Related]
24. Osteopetrosis-Associated Transmembrane Protein 1 Recruits RNA Exosome To Restrict Hepatitis B Virus Replication.
Ma C; Xu W; Yang Q; Liu W; Xiang Q; Chen J; Zhang Q; Liu Y; Wu K; Wu J
J Virol; 2020 May; 94(11):. PubMed ID: 32188736
[TBL] [Abstract][Full Text] [Related]
25. Anti-hepatitis B virus active constituents from Swertia chirayita.
Zhou NJ; Geng CA; Huang XY; Ma YB; Zhang XM; Wang JL; Chen JJ
Fitoterapia; 2015 Jan; 100():27-34. PubMed ID: 25447162
[TBL] [Abstract][Full Text] [Related]
26. Chinese herbal extract Su-duxing had potent inhibitory effects on both wild-type and entecavir-resistant hepatitis B virus (HBV) in vitro and effectively suppressed HBV replication in mouse model.
Liu Y; Yao W; Si L; Hou J; Wang J; Xu Z; Li W; Chen J; Li R; Li P; Bo L; Xiao X; Lan J; Xu D
Antiviral Res; 2018 Jul; 155():39-47. PubMed ID: 29702120
[TBL] [Abstract][Full Text] [Related]
27. In vitro and in vivo anti-hepatitis B virus activities of the lignan niranthin isolated from Phyllanthus niruri L.
Liu S; Wei W; Shi K; Cao X; Zhou M; Liu Z
J Ethnopharmacol; 2014 Sep; 155(2):1061-7. PubMed ID: 25009077
[TBL] [Abstract][Full Text] [Related]
28. Niacin analogue, 6-Aminonicotinamide, a novel inhibitor of hepatitis B virus replication and HBsAg production.
Ren F; Yang X; Hu ZW; Wong VKW; Xu HY; Ren JH; Zhong S; Jia XJ; Jiang H; Hu JL; Cai XF; Zhang WL; Yao FL; Yu HB; Cheng ST; Zhou HZ; Huang AL; Law BYK; Chen J
EBioMedicine; 2019 Nov; 49():232-246. PubMed ID: 31680002
[TBL] [Abstract][Full Text] [Related]
29. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK
J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970
[TBL] [Abstract][Full Text] [Related]
30. [Inhibitory effect of small-molecule compound AM679 targeting elongation-factor binding protein 2 on hepatitis B virus in vitro].
Fang HJ; Cai JY; Hou XX; Song JL; Peng LY; Zhu CL
Zhonghua Gan Zang Bing Za Zhi; 2024 Apr; 32(4):318-324. PubMed ID: 38733186
[No Abstract] [Full Text] [Related]
31. Metformin inhibits hepatitis B virus protein production and replication in human hepatoma cells.
Xun YH; Zhang YJ; Pan QC; Mao RC; Qin YL; Liu HY; Zhang YM; Yu YS; Tang ZH; Lu MJ; Zang GQ; Zhang JM
J Viral Hepat; 2014 Aug; 21(8):597-603. PubMed ID: 24164660
[TBL] [Abstract][Full Text] [Related]
32. [The effects of different PAP domains on hepatitis B virus replication].
Guo CX; He YW; Peng C; Lei YC; Li WT
Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):105-8. PubMed ID: 20196948
[TBL] [Abstract][Full Text] [Related]
33. Effects of SAHA on proliferation and apoptosis of hepatocellular carcinoma cells and hepatitis B virus replication.
Wang YC; Yang X; Xing LH; Kong WZ
World J Gastroenterol; 2013 Aug; 19(31):5159-64. PubMed ID: 23964152
[TBL] [Abstract][Full Text] [Related]
34. Study on 2-arylthio-5-iodo pyrimidine derivatives as novel nonnucleoside inhibitors against hepatitis B virus DNA replication.
Zhao J; Tu J; Fan N; Chen X; Lu F; Zhang Y; Zhang L; Tian C; Zhang Z; Liu J; Wang X
Future Med Chem; 2016 May; 8(7):751-63. PubMed ID: 27172826
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of the replication of hepatitis B virus in vitro by oxymatrine.
Lin M; Yang LY; Li WY; Peng YP; Zheng JK
J Int Med Res; 2009; 37(5):1411-9. PubMed ID: 19930845
[TBL] [Abstract][Full Text] [Related]
36. Three new anti-HBV active constituents from the traditional Chinese herb of Yin-Chen (Artemisia scoparia).
Geng CA; Huang XY; Chen XL; Ma YB; Rong GQ; Zhao Y; Zhang XM; Chen JJ
J Ethnopharmacol; 2015 Dec; 176():109-17. PubMed ID: 26505294
[TBL] [Abstract][Full Text] [Related]
37. In vitro and in vivo anti-hepatitis B virus activities of the lignan nirtetralin B isolated from Phyllanthus niruri L.
Liu S; Wei W; Li Y; Lin X; Shi K; Cao X; Zhou M
J Ethnopharmacol; 2014 Nov; 157():62-8. PubMed ID: 25260580
[TBL] [Abstract][Full Text] [Related]
38. In vitro resistance to interferon-alpha of hepatitis B virus with basic core promoter double mutation.
Wang Y; Wei L; Jiang D; Cong X; Fei R; Chen H; Xiao J; Wang Y
Antiviral Res; 2007 Aug; 75(2):139-45. PubMed ID: 17397939
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of hepatitis B virus replication and proteomic analysis of HepG2.2.15 cell line after cyclosporine A treatment.
Xie HY; Xia WL; Zhang CC; Wu LM; Ji HF; Cheng Y; Zheng SS
Acta Pharmacol Sin; 2007 Jul; 28(7):975-84. PubMed ID: 17588333
[TBL] [Abstract][Full Text] [Related]
40. 5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells.
Chen X; Qian Y; Yan F; Tu J; Yang X; Xing Y; Chen Z
Eur J Pharmacol; 2013 Dec; 721(1-3):86-95. PubMed ID: 24099962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]